Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews · Airways

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 25%Moderate 3 · 75%High 0 · 0%

IV + inhaled beta agonist vs inhaled beta‐agonist

Hospital admissions · patients with acute asthma

IV + inhaled beta agonist showed no clear difference in admissions to hospital compared with inhaled beta‐agonist (low certainty).

1 finding from 1 review

Addition of intravenous beta₂‐agonists to inhaled beta₂‐agonists for acute asthma 2012 · Cochrane Headline outcomes only
OR 0.29 [0.06, 1.38]
1 study · 29 participants
Low

IV + inhaled beta agonist vs inhaled beta‐agonist

Healthcare use: length of stay in the emergency department · patients with acute asthma

IV + inhaled beta agonist showed no clear difference in length of stay in emergency department compared with inhaled beta‐agonist (moderate certainty).

1 finding from 1 review

Addition of intravenous beta₂‐agonists to inhaled beta₂‐agonists for acute asthma 2012 · Cochrane Headline outcomes only
no estimate extracted
1 study · 46 participants
Moderate

IV + inhaled beta agonist vs inhaled beta‐agonist

Pulse rate at 2 hours · patients with acute asthma

IV + inhaled beta agonist showed no clear difference in pulse rate at 2 hours compared with inhaled beta‐agonist (moderate certainty).

1 finding from 1 review

Addition of intravenous beta₂‐agonists to inhaled beta₂‐agonists for acute asthma 2012 · Cochrane Headline outcomes only
MD 10
1 study · 29 participants
Moderate

IV + inhaled beta agonist vs inhaled beta‐agonist

Clinical Failure (children with a severe to moderate overall clinical assessment score at two hours) · patients with acute asthma

IV + inhaled beta agonist probably leads to lower clinical Failure (children with a severe to moderate overall… compared with inhaled beta‐agonist (moderate certainty).

1 finding from 1 review

Addition of intravenous beta₂‐agonists to inhaled beta₂‐agonists for acute asthma 2012 · Cochrane Headline outcomes only
OR 0.09 [0.02, 0.38]
1 study · 29 participants
Moderate